Delphi consensus for the third-line treatment of metastatic colorectal cancer

Purpose The optimal drug regimen and sequence are still unknown for patients with metastatic colorectal cancer (mCRC) who are candidates for third-line (3L) or subsequent treatment. The aim of this study is to know the opinion of experts on the most appropriate treatment options for mCRC in 3L and t...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical & translational oncology 2024-06, Vol.26 (6), p.1429-1437
Hauptverfasser:	García-Alfonso, Pilar, Vera, Ruth, Aranda, Enrique, Élez, Elena, Rivera, Fernando
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic Combined Chemotherapy Protocols - therapeutic use Colorectal Neoplasms - drug therapy Colorectal Neoplasms - pathology Consensus Delphi Technique Humans Medicine Medicine & Public Health Neoplasm Metastasis Oncology Proto-Oncogene Proteins B-raf - genetics Pyrrolidines - therapeutic use Quality of Life Research Article Spain Surveys and Questionnaires Thymine - therapeutic use Trifluridine - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!